Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction

International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial

(2014) Robert J. Mentz et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program

(2012) Marco Metra et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Heart Failure With Preserved Ejection Fraction

(2011) James E. Udelson   CIRCULATION

Forecasting the Future of Cardiovascular Disease in the United States

(2011) Paul A. Heidenreich et al.   CIRCULATION

Factors Associated With Outcome in Heart Failure With Preserved Ejection Fraction

(2010) Michel Komajda et al.   Circulation-Heart Failure

Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide

(2009) Hans Wedel et al.   EUROPEAN JOURNAL OF HEART FAILURE

Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition

(2008) Faiez Zannad et al.   EUROPEAN HEART JOURNAL

Cardiac Troponin and Outcome in Acute Heart Failure

(2008) W. Frank Peacock et al.   NEW ENGLAND JOURNAL OF MEDICINE

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

(2008) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE